UZ Brussel — Clinical Trial Site

248 Registered trials

106 Currently recruiting

Organisation

UZ Brussel

Location

Jette, Belgium

Identifier

ORG-100011086

Address

Laarbeeklaan 101, 1090, Belgium

Departments

/
#40575: Clinical Department of Geriatrics
032003:Pediatric gastroenterology
0507 Medical oncology
0507: Oncologisch Centrum
1103: Oncologisch Centrum
32007: Hematologie
Adult psychiatry
Anesthesiology
Anesthesiology & Peri-Operative Medicine
BE30007:Hematologie
Brussels IVF
Cardiology
Cardiology and intensive care
Center for Reproductive Medicine
Center of Reproductive Medicine
Clinical Hematology
Clinical Nutrition
Clinical Nutrition/Intensive Care
Department of Hematology
Department of Medical Oncology
Department of Neurosurgery - Neuro-oncology
Department of Paediatric Neurology and Metabolic Diseases
Dermatologie
Dermatology
Dermatology Department
Diabeteskliniek
Diabetologie
Diabetology
Diabetology & Endocrinology
Diabetology and Endocrinology
Division of Pediatric Endocrinology
Endocrinology
Gastro-enterology
Gastroenterology
Gastroenterology - hepatology
Gastroenterology and Hepatology
Geriatrics
Gynaecologie-Verloskunde
Gynaecology-Fertility
Haematology
Hematologie
Hematology
Hematology Department
Hémotologie et oncologie pédiatrique
Hepatology
Hepatopancreatobiliary Surgery
ICU
IG-infectiologie
Infectiology
Infectious Diseases
Intensive Care
Internal Medicine
Kindergastro-enterologie, hepatologie en nutritie
Kinderneurologie
Medical Hematology
Medical Oncology
Medical Oncology and Hematology
Medical Oncology Department
Medische oncologie
N/A
NA
Neonatology
Nephrology
Nephrology and Hypertension
Neurology
Neurosurgery
nuclear medicine
Oncologie
Oncology
Paediatric Endocrinology and Diabetes
Paediatric Neurology
Pediatric Gastoenterology
Pediatric gastroenterology
Pediatric Gastroenterology, Hepatology and Nutrition
Pediatric Neurology
Pediatrics
Pediatry
Physical and Rehabilitation Medicine
Pneumology
Psychiatry
Pulmonology
Radiology
Respiratory Disease
Reumatologie
Rheumatology
Universitair Ziekenhuis Brussel Medische Oncologie
UZ Brussel

Clinical trials at this site (248)

Search interface

A clinical study to investigate if the investigational product, called LN -145 (also known as Tumor Infiltrating Lymphocytes) is safe and be… Recruiting

2024-510778-26-00 Metastatic Non-Small-Cell Lung Cancer 4 2025-12-19
CLEOPATTRA: A research study to look at the effects of treatment with a medicine called coramitug (NNC6019-0001) in people with heart failur… Recruiting

2024-518899-31-00 Variant or wild-type transthyretin (TTR) amyloid cardio 5 2025-12-19
ASPIRING Recruiting

2024-516188-10-00 Intracerebral haemorrhage 6 2025-10-07
Dose-Selection, Safety and Efficacy Study with Open-Label Extension of Choline Chloride for Injection in Adolescent and Adult Patients with … Recruiting

2024-519496-26-00 Intestinal Failure 10 2025-09-25
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
A Study to Learn About the Study Medicine Called Sigvotatug Vedotin in People with Locally Advanced, Unresectable, or Metastatic Non-Small C… Recruiting

2024-517968-36-00 non-small cell lung cancer 5 2025-07-08
A Study to Assess the Effectiveness and Safety of Induction Therapy with RO7790121 in Participants with Moderately to Severely Active Crohn'… Recruiting

2024-513054-30-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A study of the efficacy and safety of Belimumab in adults with interstitial lung disease associated with connective tissue disease. Recruiting

2024-513018-36-00 Lung Diseases, Interstitial 5 2025-03-06
A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY IN PATIENTS WITH PREVIOUSLY TREATED UNRESECTABLE OR METASTATIC NRAS MUTANT CUTANEOUS MELANOMA COMPARI… Recruiting

2024-511404-17-00 Unresectable or metastatic NRAS mutant cutaneous melano 5 2024-10-07
Crohn's Disease: Pharmacokinetics, Efficacy, and Safety of Risankizumab in Pediatric Subjects with Moderately to Severely Active Crohn's Dis… Recruiting

2022-502050-14-00 Crohn's disease 5 2024-06-04
A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke Recruiting

2022-501890-38-00 acute ischemic stroke 4 2024-02-16
Clinical study to investigate the Efficacy and Safety of Encaleret Compared to Standard of Care treatment in patients with Autosomal Dominan… Recruiting

2022-501398-38-00 Autosomal Dominant Hypocalcemia Type 1 (ADH1) 5 2023-09-02
A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Ope… Recruiting

2023-509672-42-00 GRIN-related neurodevelopmental disorder 5 2023-02-02
A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral oza… Recruiting

2023-509248-86-00 Moderately to Severely Active Ulcerative Colitis 10 2022-03-11
SAFEGUARD (SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes) Study Recruiting

2025-521560-36-00 Type 1 Diabetes 4 2026-04-22
An investigational trial to evaluate the effects of the drug XC001 delivered via a catheter in subjects with chronic angina caused by corona… Recruiting

2024-514874-36-01 Refractory angina due to obstructive coronary artery di 4 2026-04-17
A study to test how well PLENVU®, a bowel cleansing medicine, works in children and teenagers before they have a colonoscopy exam Recruiting

2025-522046-42-00 Colonic disease 5 2026-03-24
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Recruiting

2025-522674-36-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2026-03-24
A trial to learn how well AZD4144 works, how safe it is, and how it moves throughout the body over time in adults with acute kidney injury c… Recruiting

2025-522232-13-00 Sepsis-associated acute kidney injury (AKI) 4 2026-03-06
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02) Recruiting

2025-522873-12-00 ER+, HER2- Advanced Breast Cancer 5 2026-02-24
A trial to learn how safe Dato-DXd is and how well it works in people with NSCLC that has advanced after receiving osimertinib Recruiting

2024-511362-37-00 Non squamous non-small cell lung cancer (NSCLC) 5 2026-02-18
Vorasidenib for the treatment of IDH-mutant astrocytoma after standard chemoradiotherapy Recruiting

2024-519404-27-00 IDH-mutant grade 2 or 3 astrocytoma 5 2026-01-16
GRAALL 2024 - A 3-cohort Randomized Study evaluating the role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Tran… Recruiting

2024-511437-35-00 Patients aged 18-65 years old with newly diagnosed prev 10 2026-01-05